US Stock MarketDetailed Quotes
OSTX OS Therapies
- 2.060
- +0.060+3.00%
Close Nov 27 16:00 ET
- 1.820
- -0.240-11.65%
Post 20:02 ET
43.75MMarket Cap-5885P/E (TTM)
2.257High1.925Low13.42KVolume2.060Open2.000Pre Close27.37KTurnover0.84%Turnover RatioLossP/E (Static)21.24MShares4.90052wk High-62.42P/B3.30MFloat Cap1.58052wk Low--Dividend TTM1.60MShs Float4.900Historical High--Div YieldTTM16.58%Amplitude1.580Historical Low2.039Avg Price1Lot Size
About OS Therapies Company
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD.
Company Profile
SymbolOSTX
Company NameOS Therapies
Listing DateAug 1, 2024
Issue Price4.00
Founded2018
CEOMr. Paul A. Romness, M.P.H.
MarketAMEX
Employees4
Fiscal Year Ends12-31
Address15825 Shady Grove Road,Suite 135
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-410-297-7793
Websitehttp://www.ostherapies.com
Company Executives
- Name
- Position
- Salary
- Paul A. Romness, M.P.H.
- President, Chief Executive Officer and Director
- 360.00K
- Gerald E. Commissiong
- Chief Business Officer
- --
- Christopher P. Acevedo
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Robert G. Petit, PhD
- Chief Medical Officer and Chief Scientific Officer
- 360.00K
- Olivier R. Jarry, M.B.A.,M.S.
- Independent Director
- --
- John Ciccio
- Independent Director
- 40.00
- Avril McKean Dieser, J.D.,M.A.
- Independent Director
- --
- Dr. Theodore F. Search, Pharm.D.,R.Ph.
- Independent Director
- 40.00
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
